Effect of Low Dose NOACS (Rivaroxaban 2.5 mg Twice Daily) on Patients Who Underwent Complex Percutaneous Coronary Intervention - Egyptian Knowledge Bank - troweb

353102

Effect of Low Dose NOACS (Rivaroxaban 2.5 mg Twice Daily) on Patients Who Underwent Complex Percutaneous Coronary Intervention

Article

Last updated: 01 Jan 2025

Overview Similar Items

Article

Efficacy and Safety of Low Dose Rivaroxaban in Patients with Anterior Myocardial Infarction

Article

Efficacy and Safety and Mortality: Monitoring the patients on Rivaroxaban

Article

Healthcare Effect and Safety of Patients with Persistent Non-Valvular Atrial Fibrillation Using NOAC and Warfarin

Article

Comparative study of safety and effectiveness of rivaroxaban and warfarin in patients with acute deep venous thrombosis

Article

Apixaban in Patients with Post-Myocardial Infarction Left Ventricular Thrombus: A Randomized Clinical Trial

Article

Rivaroxaban versus Warfarin in Treatment of Acute Lower Limb Deep Venous Thrombosis and its Affection on Quality of Life.

Article

EFFICACY AND SAFETY OUTCOMES OF RIVAROXABAN IN ACUTE DEEP VENOUS THROMBOSIS PATIENTS

Article

Safety and Mortality: Monitoring the Patients on Rivaroxaban

Article

Short Term Evaluation of Warfarin Versus Rivaroxaban Regimens in the Treatment of Deep Venous Thrombosis

Article

Assessment of rivaroxaban as venous thromboembolism prophylaxis after gastric bypass surgery